EUVIMEDEUVIMED entdecken
Crossref

TCF3 :: ZNF384 induces steroid resistance in B‐cell precursor acute lymphoblastic leukemia cells

Shinpei Kusano iD, Hitomi Ueno-Yokohata, Momoka Hori, Takeshi Ishibashi, Junya Fujimura, Toshiaki Shimizu iD, Kentaro Ohki, Nobutaka Kiyokawa iD

Pediatrics International · 2025-01 · 67 (1)

DOI: 10.1111/ped.70078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 20.05.2025. Verfasst von Shinpei Kusano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Japan. Hauptthemen laut MEDLINE: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Drug Resistance, Neoplasm, Trans-Activators, Basic Helix-Loop-Helix Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, National Center for Child Health and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

ZNF384 rearrangements ( ZNF384 ‐r) are associated with distinct subgroups of B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL) and the mixed phenotype of acute leukemia. Types of BCP‐ALL with ZNF384 ‐r exhibit common immunophenotypic characteristics, whereas their clinical features are not uniform and TCF3::ZNF384 ‐positive patients show a significantly poorer steroid response and higher frequency of relapse, while EP300::ZNF384 ‐positive patients exhibit a favorable response to conventional chemotherapy. Therefore, we aimed to investigate the differences in biological effects between these two ZNF384‐r molecules.

Method

We transduced BCP‐ALL cell lines with both TCF3::ZNF384 and EP300::ZNF384 by retrovirus‐mediated gene transduction, and examined the biological effects.

Results

Flow cytometric analysis and RT‐qPCR revealed down‐regulation of CD10 in BCP‐ALL cells after transduction with both TCF3::ZNF384 and EP300::ZNF384. The annexin‐V binding apoptosis assay indicated that TCF3::ZNF384‐, but not EP300::ZNF384‐, expressing cells exhibited increased resistance to dexamethasone‐induced apoptosis. By means of an oligonucleotide microarray and RT‐qPCR, we observed that the transduction of TCF3::ZNF384 , but not EP300::ZNF384 , leads to significant enhancement of cyclin D2 ( CCND2 ) gene expression in BCP‐ALL cells, but no growth advantage was observed.

Conclusion

Our data suggest that the acquisition of dexamethasone resistance in BCP‐ALL cell lines is an effect of TCF3::ZNF384 protein distinct from EP300::ZNF384. Other than the common functions of ZNF384‐r that contribute to the development of leukemia with a lineage‐ambiguous phenotype, TCF3::ZNF384 may exhibit a fusion partner‐dependent function distinct from EP300::ZNF384 and participate in the formation of characteristic clinical features of TCF3 :: ZNF384 ‐expressing ALL patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor B-Cell Lymphoblastic Leukemia-LymphomaDrug Resistance, NeoplasmTrans-ActivatorsBasic Helix-Loop-Helix ProteinsHumansApoptosisE1A-Associated p300 ProteinCell Line, Tumor

Stichwörter der Autor:innen

EP300::ZNF384TCF3::ZNF384acute lymphoblastic leukemiacell linesteroid resistance

Substanzen

Trans-ActivatorsBasic Helix-Loop-Helix ProteinsE1A-Associated p300 ProteinTCF3 protein, humanZNF384 protein, humanEP300 protein, human

Autor:innen und Institutionen

  • Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Setagaya-ku, Japan.
  • Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan.
  • Graduate School of Engineering Science, Yokohama National University, Yokohama, Japan.

ORCID-Profile: Shinpei Kusano, Toshiaki Shimizu, Nobutaka Kiyokawa

Förderung

  • Japan Agency for Medical Research and Development
  • National Center for Child Health and Development

Zitieren

APA

Kusano, S., Ueno-Yokohata, H., Hori, M., Ishibashi, T., Fujimura, J., Shimizu, T., Ohki, K., & Kiyokawa, N. (2025). TCF3 :: ZNF384 induces steroid resistance in B‐cell precursor acute lymphoblastic leukemia cells. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70078

Vancouver

Kusano S, Ueno-Yokohata H, Hori M, Ishibashi T, Fujimura J, Shimizu T, et al. TCF3 :: ZNF384 induces steroid resistance in B‐cell precursor acute lymphoblastic leukemia cells. Pediatrics International. 2025;67(1). doi:10.1111/ped.70078

BibTeX
@article{Kusano2025,
  author = {Kusano, Shinpei and Ueno-Yokohata, Hitomi and Hori, Momoka and Ishibashi, Takeshi and Fujimura, Junya and Shimizu, Toshiaki and Ohki, Kentaro and Kiyokawa, Nobutaka},
  title = {TCF3 :: ZNF384 induces steroid resistance in B‐cell precursor acute lymphoblastic leukemia cells},
  journal = {Pediatrics International},
  year = {2025},
  volume = {67},
  number = {1},
  doi = {10.1111/ped.70078}
}
Kostenlos starten →